By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Structural GenomiX, Inc. 

10505 Roselle Street

San Diego  California  92121  U.S.A.
Phone: n/a Fax: n/a



Company News
Structural GenomiX, Inc. And Cystic Fibrosis Foundation Solve Crystal Structure Of Integral Disease-Causing Region Of Cystic Fibrosis Protein To Reveal Critical And Previously Undiscovered Change10/19/2005 5:12:20 PM
Structural GenomiX, Inc. Achieves All Year-One Milestones In Eli Lilly and Company (LLY) Collaboration10/19/2005 5:11:34 PM
Structural GenomiX, Inc. Acquires Anti-Cancer Agent From Shire BioChem, Inc. 10/19/2005 5:11:21 PM
Structural GenomiX, Inc. Appoints Neill Giese, Ph.D. As Senior Vice President Of Drug Development10/19/2005 5:11:00 PM
Structural GenomiX, Inc. Forms Drug Discovery Collaboration With Serono (SRA) Utilizing Proprietary SGX FAST(TM) Lead Generation; Up To $68 Million10/19/2005 5:10:33 PM
RoboDesign International, Inc. To Provide Custom High-Throughput Crystallization Solution For Structural GenomiX, Inc.10/19/2005 5:10:32 PM
FDA Grants Structural GenomiX, Inc. Orphan Drug Designation For Troxatyl(TM); SGX To Present Troxatyl(TM) Clinical Data At American Society of Clinical Oncology10/19/2005 5:10:15 PM
Roche (RHHBY) And Structural GenomiX, Inc. Enter New Anti-Viral Drug Discovery Partnership10/19/2005 5:10:14 PM
Structural GenomiX, Inc. Reports Interim Clinical Data Of Troxatyl(TM) (Troxacitabine) Anti-Cancer Drug For Acute Myelogenous Leukemia At 2005 American Society of Clinical Oncology Annual Meeting10/19/2005 5:10:03 PM
Structural GenomiX, Inc. Expands Relationship With Eli Lilly and Company (LLY)10/19/2005 5:09:40 PM